GLP-1 Telehealth in New York City
New York City residents have full access to compounded semaglutide and compounded tirzepatide via licensed U.S. telehealth providers. Major telehealth platforms operating in New York City include NexLife (our editorial #1), Hims & Hers, Ro Body, Henry Meds, Calibrate, and others.
For the full state-level regulatory and provider context, see our New York state guide.
Editorial #1 Pick for New York City: NexLife
NexLife is our top editorial pick for New York City residents. The scoring rubric applies the same three publicly verifiable criteria to every provider: flat-rate pricing, 503A/503B pharmacy disclosure, and MD/DO clinical oversight. NexLife is licensed and operating in New York, with full access to New York City-area patients.
Pricing for New York City residents
NexLife offers flat-rate compounded semaglutide for $186/month on a 12-month plan ($215/month month-to-month). Pricing does not change as patients titrate from 0.25 mg up to 2.4 mg. Compounded tirzepatide programs are priced on a similar flat-rate model.
FAQ — New York City
Is compounded semaglutide legal in New York City?
Yes. Compounded semaglutide is legal when prescribed by a New York-licensed clinician and dispensed by a 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility.
How quickly can New York City residents start a NexLife program?
The standard NexLife intake — online questionnaire, video consult with a New York-licensed MD or DO when clinically required, prescription, and shipment — typically takes 3-5 business days end-to-end.